Welcome to the medtech[y] message boards

The medtech[y] guarantee. Always anonymous…guaranteed
Always anonymous…guaranteed

Add your voice to the conversation

Welcome to the boards. Below you’ll find the latest conversations.

Start a conversation by viewing the boards above or begin by rating your company below… anonomously of course!

Salaries

In our drive to help people in the medical sales industry we are gathering salary data. This information will be collated, analyzed and number crunched. Medtechy’s overall goal is to help the medical sales industry make more informed decisions when changing jobs and also keep employers and recruiters honest

Take 30 seconds and let us know your current deal.*

About The Position

Compensation

* We guarantee all data collected is completely anonymous and will only be used for the benefit of future visitors.

×

Insightec raises $150m in Series E

2 days ago

Insightec said yesterday it raised $150 million in a Series E round of financing led by Koch Industries’ Koch Disruptive Technologies to support its MRI-guided focused ultrasound technologies. The round was led by Koch Disruptive Technologies and joined by existing investors Elbit Imaging, York Capital, Focus Holdings, GE Healthcare (NYSE:GE), GEOC and Meditech Advisors, the Israel-based company […]

The post Insightec raises $150m in Series E appeared first on MassDevice.

European committee backs Novo Nordisk’s once-weekly Type II diabetes therapy

2 days ago

A panel of experts from the European Medicines Agency issued a positive recommendation today for Novo Nordisk‘s (NYSE:NVO) once-weekly diabetes drug, Ozempic. The committee’s recommendation will need to be endorsed by the European Commission before the insulin-maker’s product can be formally marketed in the EU. Get the full story at our sister site, Drug Delivery Business News.

The post European committee backs Novo Nordisk’s once-weekly Type II diabetes therapy appeared first on MassDevice.

CompactCath wins CE Mark for compact intermittent urinary cath

2 days ago

CompactCath said this week it won CE Mark approval in the European Union for its flagship CompactCath intermittent urinary catheter. The Palo Alto, Calif.-based company’s CompactCath device is a unisex catheter designed for use in both pediatric and adult patients. The 16-inch device features coiled packaging, which the company says makes it the only such […]

The post CompactCath wins CE Mark for compact intermittent urinary cath appeared first on MassDevice.

OrthoMidwest

2 days ago in Depuy Synthes Message Board board

There is an associate position open in Pittsburgh. Is this the same type of pay you can expect for that position?


Zimmer & Amedica Partnership Inevitable

2 days ago in Zimmer Biomet Message Board board

Most people who know about Amedica know that Amedica makes spined based products. However, Silicon Nitride is not limited to just the spine markets. I thought i would take a moment to highlight the various products that Amedicas Silicon Nitride has currently been commercialized for, products in development, & potential products in the future. I’ll also touch on the potential global market sizes of each product line to the best of my ability.

Amedica’s Silicon Nitride: Current and Potential Markets

Most people who know about Amedica know that Amedica makes spined based products. However, Silicon Nitride is not limited to just the spine markets. I thought i would take a moment to highlight the…

Vascular Dynamics taps ex-Ellipse Tech CEO Roschak as chief exec | Personnel Moves December 15, 2017

2 days ago

Vascular Dynamics said early this month it tapped former NuVasive Inc. (NSDQ:NUVA) exec and Ellipse Technologies CEO Ed Roschak as its new president and chief executive. Prior to joining Mountain View, Calif.-based Vascular Dynamics, Roschak served as prez and CEO of Ellipse Technologies, which he saw through a $410 million acquisition by NuVasive. He then took up […]

The post Vascular Dynamics taps ex-Ellipse Tech CEO Roschak as chief exec | Personnel Moves December 15, 2017 appeared first on MassDevice.

Has Titan Medical missed the window in the robotic surgery market?

2 days ago in Titan Medical Message Board board

I agree BSC would be a good target but I think the author brought up a good point in the post: will SPORT still be competitive in 2019?

If it's true that Intuitive is working on haptic, etc then why wouldn't a hospital just go with a da Vinci? A lot of the benefits like cost will br thrown out the window by then because Intuitive will have so many options for customers. I think they already offer low cost options, like used equipment.

Just curious your opinion because a lot changes in 2 years.

Loading...

Email Newsletter Subscription.

Don’t you think it’s about time your (day) job got a bit easier? Us too.

Register today and we’ll add you to our mailing list.

I am a